Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Ayala de la Pena F, Ortiz-Munoz B, Quintanar-Verduguez T, Santotoribio JD, de la Cruz S, Trape-Pujol J, Galve-Calvo E, Auge-Fradera JM, Garcia-Gomez J, Gonzalez-Hernandez A. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer. Clin Transl Oncol. 2021 Jul;23(7):1272-1280. doi: 10.1007/s12094-020-02529-x. Epub 2021 Feb 7. PubMed PMID: 33550504; PubMed Central PMCID: PMC8192375.
AÑO: 2021; IF: 3.34
33550504
Palma-Barqueros V, Bury L, Kunishima S, Lozano ML, Rodriguez-Alen A, Revilla N, Bohdan N, Padilla J, Fernandez-Perez MP, de la Morena-Barrio ME, Marin-Quilez A, Benito R, Lopez-Fernandez MF, Marcellini S, Zamora-Canovas A, Vicente V, Martinez C, Gresele P, Bastida JM, Rivera J. Expanding the genetic spectrum of TUBB1-related thrombocytopenia. Blood Adv. 2021 Dec 28;5(24):5453-5467. doi: 10.1182/bloodadvances.2020004057. Erratum In: Blood Adv. 2023 Mar 28;7(6):877. PubMed PMID: 34516618; PubMed Central PMCID: PMC8714720.
AÑO: 2021; IF: 7.637
34516618
Fernandez Montes A, Carmona-Bayonas A, Jimenez-Fonseca P, Vazquez Rivera F, Martinez Lago N, Covela Rua M, Cousillas Castineiras A, Gonzalez Villarroel P, De la Camara Gomez J, Mendez JCM, Carriles Fernandez C, Sanchez Canovas M, Garcia Garcia T. Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data. Sci Rep. 2021 Jul 12;11(1):14321. doi: 10.1038/s41598-021-93732-5. PubMed PMID: 34253805; PubMed Central PMCID: PMC8275736.
AÑO: 2021; IF: 4.996
34253805
Ribera JM, Morgades M, Genesca E, Chapchap EC, Montesinos P, Acuna-Cruz E, Gil C, Garcia-Cadenas I, Barba P, Gonzalez-Campos J, Queipo de Llano MP, Torrent A, Ribera J, Granada I, Bernal T, Diaz-Beya M, Amigo ML, Coll R, Tormo M, Vall-Llovera F, Gomez-Centurion I, Sanchez-Sanchez MJ, Soria B, Cladera A, Artola MT, Garcia-Guinon A, Gimenez-Conca A, Amador ML, Martinez-Sanchez P, Algarra JL, Vidal MJ, Alonso N, Maluquer C, Llorente L, Garcia-Boyero R, Ciudad J, Feliu E, Orfao A; on behalf of the PETHEMA Group. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials. Hematol Oncol. 2021 Oct;39(4):529-538. doi: 10.1002/hon.2910. Epub 2021 Aug 18. PubMed PMID: 34405901.
AÑO: 2021; IF: 4.85
34405901
Barbui T, De Stefano V, Carobbio A, Iurlo A, Alvarez-Larran A, Cuevas B, Ferrer Marin F, Vannucchi AM, Palandri F, Harrison C, Sibai H, Griesshammer M, Bonifacio M, Elli EM, Trotti C, Koschmieder S, Carli G, Benevolo G, Ianotto JC, Goel S, Falanga A, Betti S, Cattaneo D, Arellano-Rodrigo E, Mannelli L, Vianelli N, Doyle A, Gupta V, Wille K, Tremblay D, Mascarenhas J. Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients. Leukemia. 2021 Oct;35(10):2989-2993. doi: 10.1038/s41375-021-01279-1. Epub 2021 May 19. No abstract available. PubMed PMID: 34012132; PubMed Central PMCID: PMC8132485.
AÑO: 2021; IF: 12.883
34012132
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL